<p>Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions</p>
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.